Studying brain tumors called gliomas in people on Reunion Island
Follows people with glioma to learn about their health, care and daily lives.
Plain-language title generated from the registry record
Registry title: Diffuse Gliomas in Reunion Island: Establishment of an Epidemiological, Clinical-biological and Socio-anthropological Cohorte
Key facts
- Where
- Saint-Pierre, RéunionSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for adults living on Reunion Island who were diagnosed with a new diffuse glioma since January 1, 2018. Healthcare workers who care for people with brain tumors can also take part.
- Age
- Patients 18 years and older.
- Sex
- All sexes.
- Disease stage
- Newly diagnosed diffuse glioma, confirmed by tissue examination (histology), diagnosed since January 1, 2018.
Main reasons for not taking part
- Diffuse glioma that has come back (recurrent)
- Refusing to take part in the study
- Person deprived of liberty by a judicial or administrative decision
- Person under a legal protection measure (guardianship, curatorship)
- For the interview part: not speaking French, or serious health problems that make an interview impossible
Read by machine on 12 November 2026.
Where in Réunion
- Mélanie BEGORRESaint-Pierre, RéunionContact: CHU La Réunion DRCITaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Centre Hospitalier Universitaire de la Réunion
- Trial code
- NCT07865195
- Record updated
- 8 October 2026
- Original description
To date, very little data exists on gliomas in the Réunion population, in terms of epidemiology, socio-cultural aspects, clinical or biological factors, and care pathways. However, the Réunion population is multicultural and highly cosmopolitan, experiencing rapid aging, and its socio-economic indicators are among the most pessimistic of all French departments. Furthermore, the healthcare services available on the island are less comprehensive than those in metropolitan France (Insee 2018). Finally, the management of patients with gliomas, particularly high-grade gliomas, remains very complex, with significant medical and social challenges (supportive care, end-of-life care, etc.). Healthcare professionals agree that these specialized facilities are insufficient to meet the care needs in Réunion (post-acute care, palliative care units, supportive care, etc.).Read full original descriptionShow less
Diffuse Gliomas in Reunion Island: Establishment of an Epidemiological, Clinical-biological and Socio-anthropological Cohorte
To date, very little data exists on gliomas in the Réunion population, in terms of epidemiology, socio-cultural aspects, clinical or biological factors, and care pathways. However, the Réunion population is multicultural and highly cosmopolitan, experiencing rapid aging, and its socio-economic indicators are among the most pessimistic of all French departments. Furthermore, the healthcare services available on the island are less comprehensive than those in metropolitan France (Insee 2018). Finally, the management of patients with gliomas, particularly high-grade gliomas, remains very complex, with significant medical and social challenges (supportive care, end-of-life care, etc.). Healthcare professionals agree that these specialized facilities are insufficient to meet the care needs in Réunion (post-acute care, palliative care units, supportive care, etc.).
GlioRun is a retrospective and prospective mixed-methods cohort study, combining epidemiological and socio-anthropological approaches, which aims to produce data to improve care and the experiences of patients and their relatives on Reunion Island, and reduce the number of medical evacuations to mainland France.
Inclusion: Quantitative study (retrospective and prospective components):; Patients aged 18 and over:; With a histological diagnosis of incident diffuse glioma since January 1, 2018; Residing in Réunion at the time of diagnosis,; Having been informed about the study procedures; Having agreed to participate in the study; Socio-anthropological study (prospective component):; Patients:; Meeting the inclusion criteria for the prospective quantitative study and agreeing to participate in the qualitative component,; Speaking French. • Able to participate in a face-to-face interview; Healthcare Professional:; Professionals involved in the care of patients with brain tumors (medical, paramedical, social care, support care, etc.) who have agreed to participate in the study; The healthcare professionals concerned will be general practitioners, neurosurgeons, neurologists, radiation oncologists, medical oncologists, home healthcare physicians, palliative care physicians, pathologists, nurses responsible for diagnosis and follow-up, psychologists, social workers, and dietitians.
Exclusion: Regarding the quantitative study:; Patient:; Refusing to participate in the quantitative study Having a recurrent diffuse glioma Person deprived of their liberty and judgment by judicial or administrative decision, and person subject to a legal protection measure: guardianship or curatorship, under judicial protection, under legal guardianship, etc.); Regarding the socio-anthropological study:; Patient:; Refusing to participate in the qualitative study Does not speak French Having serious somatic or mental health problems incompatible with the interview Healthcare professionals: Refusing to participate in the study.